Stent having adjacent elements connected by flexible webs

Abstract
A stent incorporating flexible, preferably polymeric, connecting elements into the stent wherein these elements connect adjacent, spaced-apart stent elements. Preferably the spaced-apart adjacent stent elements are the result of forming the stent from a helically wound serpentine wire having space provided between adjacent windings. Other stent forms such as multiple, individual spaced-apart ring-shaped or interconnected stent elements may also be used. The connecting elements are typically web-shaped and result from creating slits or apertures in a covering of graft material applied to the stent and then, for example, applying heat to cause the slits or apertures to enlarge. The remaining graft material forms the interconnecting webs between the adjacent stent elements.
Description
FIELD OF THE INVENTION

The present invention relates to the field of implantable stents having flexibly connected adjacent stent elements.


BACKGROUND OF THE INVENTION

The use of implantable stents in the vasculature and other body conduits has become commonplace since first proposed by Dotter in the 1960's. These devices are required to have a small, compacted diameter for insertion into an intended body conduit and transport, typically via a catheter, to a desired site for deployment, at which site they are expanded to a larger diameter as necessary to fit interferably with the luminal surface of the body conduit. Balloon expandable stents are expanded by plastically deforming the device with an inflatable balloon on which the expandable stent was previously mounted in the compacted state, the balloon being attached to the distal end of the catheter and inflated via the catheter. Self-expanding stents are forcibly compacted to a small diameter and restrained at that diameter by a constraining sleeve or other means. Following delivery to a desired site for deployment, they are released from the restraint and spring open to contact the luminal surface of the body conduit. These devices are typically made from nitinol metal alloys and typically rely on the superelastic and biocompatible character of this metal. Nitinol stents that rely on the shape memory attributes of that material are also known.


The evolution of implantable stents has also included the use of a tubular covering fitted to the stent, either to the outer surface, the luminal surface or to both surfaces of the stent. These covered stents have generally come to be referred to as stent-grafts. The coverings are generally of a polymeric biocompatible material such as polyethylene terephthalate (PET) or polytetrafluoroethylene (PTFE). See, for example, U.S. Pat. No. 4,776,337 to Palmaz.


The Palmaz '337 patent also describes that the covering may be optionally provided with perforations if desired for particular applications. Because of the open area provided by the perforations, such devices having perforated coverings may be considered to be a sort of hybrid stent and stent-graft, as are devices that include stent frames having metallic stent elements and polymeric elements connecting, covering or other otherwise being attached to the stent elements. The presence of the polymeric elements reduces the otherwise open space between the adjacent metallic stent elements, either very slightly or very substantially depending on the intended application and mechanical design. Perforated stent-grafts are also described elsewhere; see, for example WO00/42949.


Stents having stent elements provided with polymeric coatings or coverings are also known; see, for example, U.S. Pat. No. 5,735,892 to Myers et al. and U.S. Pat. No. 5,968,091 to Pinchuk et al.


Generally, a fully covered stent-graft can be considered to have a surface area (hereinafter Amax) equal to the outer circumference of the expanded stent multiplied by the length of the stent. For a conventional, open frame stent (as opposed to a stent-graft), the surface area represented by all of the stent elements is only a small portion of the maximum surface area Amax. The actual surface area covered by the stent, meaning the area covered by all components of the stent (including connecting elements) in their deployed state, is Astent. The porosity index, or P.I., describes the open area (the portion of the maximum surface area not covered by all components of the stent assembly) as a percentage of maximum surface area, wherein:

P.I.=(1−(Astent/Amax))×100%.


A preferred method of measuring the actual surface area covered by the stent (Astent), involves the use of a machine provided Visicon Inspection Technologies, LLC (Napa, CA). The Visicon Finescan™ Stent Inspection System (Visicon Finescan machine model 85) uses a 6000 pixel line scan camera to generate a flat, unrolled view of a stent. In operation, the stent is mounted on a sapphire mandrel with a fine diffuse surface. This mandrel is held under the linear array camera and rotated by the system electronics and is used to trigger the linear array camera to collect a line of image data in a precise line-by-line manner. After a complete revolution an entire image of the stent is acquired. When the entire stent has been imaged, the software differentiates between the stent with cover and the background. The total number of picture elements (pixels) is compared to the total number of pixels associated with the stent and cover to determine Astent. Basic settings on the machine used for this type of determination are (for example): light, 100%; exposure, 0.3 ms/line; gain, 5; threshold, 50; noise filter, 20; smoothing, 4.


The open area may be a continuous single space, such as the space between windings of a single helically wound stent element. Likewise the open area may be represented by the space between multiple individual annular or ring-shaped stent elements. The open area may also be represented by the total area of multiple apertures provided by either a single stent element (e.g., as shown by FIGS. 1B and 2B of U.S. Pat. No. 4,776,337 to Palmaz) or by multiple stent elements providing multiple apertures. If multiple apertures are provided they may be of equal or unequal sizes. The use of a perforated graft covering or of polymeric elements in addition to metallic stent elements may also reduce the open area.


Stents having a porosity index of greater than 50% are considered to be substantially open stents.


In addition to the porosity index, the size of any aperture providing the open area must be considered if it is intended to cover only a portion of a stent area for a specific stent application. For multiple apertures, often the consideration must be for the largest size of any individual aperture, particularly if the apertures are to provide for a “filtering” effect whereby they control or limit the passage of biologic materials from the luminal wall into the flow space of the body conduit.


Various stent devices combining metallic stent elements with polymeric connecting elements are known; see, for example U.S. Pat. No. 5,507,767 to Maeda et al. Another is a stent provided with a flexible knitted sleeve having small open apertures in the fashion of chain link fencing, from InspireMD Ltd. (4 Derech Hashalom St., Tel Aviv 67892 Israel).


SUMMARY OF THE INVENTION

An open stent (a stent having open space through its thickness at locations between the ends of the stent) and method of making are described. The stent incorporates flexible, preferably polymeric connecting elements (i.e., polymeric webs) into the stent wherein these connecting elements connect adjacent, spaced-apart stent elements. The flexible, preferably polymeric connecting elements provide a means for keeping the stent elements equally spaced and allow the construction of a stent having good flexibility and a useful resistance to forces that may be applied to the device in vivo such as torsional forces, bending forces, axial tension or compression, or radial compression.


Preferably the spaced-apart adjacent stent elements are in the form of a helically wound serpentine wire having space provided between adjacent windings. Other stent forms such as multiple, individual spaced-apart ring-shaped stent elements may also be used. Ring shaped stent elements may be in the form of zig-zag elements creating a circumferential ring, or interconnected elements that provide diamond shaped openings in a circumferential sequence when the device is diametrically expanded. Alternatively, embodiments presented that utilize the helically wound serpentine forms are preferred for many applications. The stent is preferably self-expanding (made from materials such as nitinol) but may also be made from materials suitable for balloon expandable stents (e.g., stainless steel, magnesium based alloys, magnesium, cobalt chromium alloy, titanium or titanium based alloys).


Helically wound stent frames are inherently unstable in absence of a secondary linkage connecting adjacent rows. Utilization of the described polymer web linkage to interconnect adjacent rows stabilizes the helical structure and limits axial elongation, torsion and bending while allowing a high degree of flexibility.


The adjacent, spaced-apart stent elements are preferably substantially circumferentially oriented, meaning that they have a general direction of orientation perpendicular to the longitudinal axis of the stent, when the stent is in a straight, unbent state.


A method of making involves the application of a biocompatible polymeric covering to the chosen stent form to create, temporarily, a stent-graft. The covering is preferably of a strong and thin material and may be in a tubular form, although sheet forms (e.g., relatively wide films cut into narrow tapes) are preferred for manufacturing as will be described. The covering is preferably applied to the outer surface of the stent, but may be applied only to the luminal surface, or alternatively may be applied to both the luminal and abluminal (outer) surfaces of the stent. Covering both the luminal and abluminal surfaces allows for the possibility of covering substantially all of the metallic surfaces of the stent with the desired polymer. The polymeric film covering is preferably a thermoplastic film, and preferably a film with strength properties that result in relatively uniform directional shrinking properties when the film is subjected to heat above its melt point. The film-covered stent graft is provided with punctures (slits or other apertures) through the thickness of the film, preferably at locations between adjacent stent elements as will be further described. The punctured stent-graft is then exposed to heat above the melt temperature of the film which causes the film to shrink back from the edges of the previously created puncture, resulting in openings through the wall of the stent. These openings are of size, shape, quantity and orientation that are a result of the size, shape, quantity and orientation of the previously created punctures, the amount of heat subsequently applied and the thickness and type of polymeric film used. It is apparent that these are manufacturing variables that may be controlled as desired. The resulting open area of the stent (i.e., porosity index) may cover a wide range (i.e., 10%, 20%, 30%, 40%, 50%, 60%, 70%, 75%, 80%, 85%, 90%, 95%, or higher, or between any of these percentages). The remaining polymeric film following the heating step is in the form of polymeric webs extending between the adjacent stent elements.


An alternate method of making also involves the application of a biocompatible polymeric covering to the chosen stent form to create, temporarily, a stent-graft. A preferable stent form in this instance would be ring shaped stent elements made from a suitable balloon expandable material. The covering is similar to that described previously and may be applied to the chosen stent form similarly to the methods described in the previous section. The polymeric film covering is preferably a thermoplastic film, and preferably a film with unidirectional strength properties. The film-covered stent graft is provided with punctures (slits or other apertures) through the thickness of the film, preferably at locations between adjacent stent elements as will be further described. The punctured stent graft is then exposed to heat sufficient to bond the film to the stent form. When the resulting stent is diametrically expanded, these openings are of size, shape, quantity and orientation that are a result of the size, shape, quantity, and orientation of the previously created punctures. It is apparent that these are manufacturing variables that may be controlled as desired. The resulting open area of the stent (i.e., porosity index) may cover a wide range such as previously described. The remaining polymeric film following the puncturing/slitting step is in the form of polymeric webs extending between and interconnecting the adjacent stent elements.


Further, the finished open frame stent may optionally be provided with another covering of polymeric graft material to create a stent-graft if desired. This graft covering is easily adhered or bonded to the covering or coating that is provided over the stent elements (e.g., the wire) and forms the interconnecting webs.


The polymeric covering of these finished devices (that include a multiplicity of openings and a multiplicity of polymeric interconnecting webs) is generally continuous or substantially continuous between the stent ends, being the result of having been made from a continuous sheet of film or the result using helically wrapped polymeric tape with overlapping adjacent edges that are melt-bonded together. The film covering that forms these continuous webs is well adhered to the stent elements.


Still further, these devices may be provided with coatings (preferably elutable coatings) of various therapeutic agents (e.g., heparin) by various means known in the art that are suitable to the particular agent.


Stents made as described herein have good conformability enabled by the flexible interconnecting webs between adjacent stent elements that provide flexibility and anatomic apposition. They also have good flexural durability enabled by interconnecting webs between adjacent stent elements that mitigates fracture due to cyclic longitudinal bending in curved anatomies. The expandable device is scalable to accommodate a range of vessel sizes (e.g. 3 mm-55 mm).


The potential clinical applications of the expandable device described herein include but are not limited to: congenital defects (i.e., pulmonary artery stenosis, aortic coarctation), adjunctive aortic therapy (i.e., Type I endoleaks; aortic side branch stenting), peripheral artery disease (i.e., renal and iliac artery stenosis, aneurysm, and dissection) and venous applications.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A and 1B describe respectively a perspective view and a plan view of a helically wound serpentine wire form (previously known) of a preferred stent as described herein.



FIG. 2A is a side perspective view of a portion of a helically wound serpentine wire stent provided with flexible interconnecting webs between adjacent stent elements.



FIG. 2B is a flattened, plan view of the stent of FIG. 2A.



FIGS. 2C and 2D are plan views wherein each single opening shown by FIG. 2B is replaced by multiple apertures, specifically four openings in FIG. 2C and six openings in FIG. 2D.



FIG. 3 is a scanning photomicrographs of a multiaxial ePTFE film useful for making the described open frame stent.



FIG. 4 shows a side view of a partially completed stent provided with slits or punctures that are part of the process of manufacturing the device.



FIGS. 5A-5C show transverse cross sectional views of a stent element as it may appear for a finished stent made as described herein.



FIG. 6A is a side perspective view of a balloon expandable stent (or a length portion of such a stent) provided with flexible interconnecting webs between adjacent stent elements.



FIG. 6B is a side perspective view of three stent rings shown without the interconnecting polymeric covering.



FIG. 6C is a side perspective view of the stent assembly comprising the stent rings shown in 6B provided with the interconnecting polymeric covering.



FIG. 6D is the upper left section of the stent assembly described by FIG. 6C, shown as a perspective detail.



FIG. 7 is a side perspective view of a balloon expandable stent (or a length portion of such a stent) provided with flexible interconnecting webs between adjacent stent elements.



FIG. 8 is a schematic side view of stent as it would appear when mounted on a balloon for subsequent deployment and expansion.





DETAILED DESCRIPTION OF THE DRAWINGS

It has been noted that a variety of stent forms may be usefully provided with the flexible connecting elements taught herein. FIG. 1A shows a perspective view of a stent 10 that is preferred for use as described herein. The stent 10 shown comprises a helical winding of a length of serpentine wire 18. Sequential windings of the helical wound serpentine wire 18 result in spaced-apart adjacent stent elements 12. The ends 17 of wire 18 may be secured by any suitable method (e.g., welding) to the adjacent helical winding. For clarity, stent 10 is shown with a mandrel 16 extending through and beyond both ends of the stent lumen, making the side closest to the viewer visually apparent while blocking the view of the side of stent 10 furthest from the viewer. Mandrel 16 is present only for clarity of visualization and is not a part of stent 10.


The helically wound serpentine wire 18 extends continuously between opposing ends of stent 10, wherein opposing apices 22a and 22b formed of wire bends of relatively small radii are interconnected by straight or relatively straight wire segments 24. The apices typically “point” in directions that are substantially parallel to the longitudinal axis 19 of the mandrel 16 and the tubular form of the stent 10, with alternating apices 22a and 22b pointing in opposite directions, that is, pointing to opposite ends of the stent. As shown by FIG. 1A, it is preferred that apices pointing in one direction (e.g., apices 22a) are aligned along a first common line while the apices pointing in the opposite direction (e.g., apices 22b) are aligned along a second common line that is parallel to the first common line.



FIG. 1B shows a plan (or flattened) view of details of the serpentine wire form described by FIG. 1A; dimensions relate to the method of making described below. Dimension 27 is considered as the height (amplitude) of adjacent opposing apices while dimension 28 is the width of adjacent opposing apices. Dimension 29 describes one full period of the serpentine form. Wire diameter 25 and bend radius 26 of the apices 22 may be chosen as appropriate.



FIG. 2A is a side perspective view of a portion of the length of an open-frame stent 10 wherein spaced-apart, adjacent stent elements 12 (e.g., two adjacent apices 22a connected to opposing apex 22b) are interconnected by a pair of flexible polymeric webs 32. FIG. 2B shows a flattened plan view of this same construction. Openings 34 exist between adjacent aligned apices 22a; the particular single openings 18 are generally in the shape of a guitar pick. If one drew a line through the center of the length of an individual, randomly selected web (i.e., extending between the adjacent wire apices joined by that web), that line would preferably form an angle of between 15 and 75 degrees with respect to a line parallel with the centerline of the stent (or parallel with the centerline 19 of mandrel 16 shown in FIG. 1). Said otherwise, for this type of stent with elements interconnected by flexible webs 32, the webs 32 preferably are oriented at an angle to the length of the stent.


The enlarged portion of FIG. 2B shows how these flexible polymeric webs 32 are narrower at the middle of their length than at the ends where they are attached to the stent element (e.g. the nitinol wire). It also shows how the webs 32 preferably merge tangentially into the stent element where they are joined to and attached to the stent element.



FIGS. 2C and 2D are plan views wherein each single opening shown by FIG. 2B is replaced by multiple apertures, specifically four openings in FIG. 2C and six openings in FIG. 2D.


While various polymeric films may be suitable for use as the stent covering (or coating) material for this device, combinations of FEP (fluorinated ethylene propylene) films used in combination with ePTFE films are preferred. The preferred ePTFE films for use with these helically wound serpentine wire stents are films having multiaxial fibrillar orientations as shown by the scanning electron photomicrograph of FIG. 3. It is seen how the fibrils are oriented in all directions within the plane of the ePTFE film. ePTFE films of this type may be made as taught by U.S. Pat. No. 7,306,729 and US Published Patent Application 2007/0012624 to Bacino et al. Films of this same type may optionally be provided with a partial covering of a thin layer of FEP (having openings through the FEP film covering; i.e., a discontinuous covering). FEP coated ePTFE films, with either a discontinuous (porous) FEP covering (coating) or a continuous (non-porous) FEP covering (coating) may be made generally as taught by U.S. Pat. No. 5,735,892 to Myers et al.



FIG. 4 shows a partially finished stent 13 of helically wound serpentine wire provided with a first outer (abluminal) covering of FEP film and an additional covering of multiaxial ePTFE film, wherein longitudinally oriented slits 41 have been made through the film between adjacent apices of the wire that are pointed in the same direction. Heat will be applied to the device having the multiple slits 41, causing the films to shrink back toward the adjacent wire stent elements, subsequently resulting the openings in the finished stent 15 (FIG. 2A). This process is described in further detail below.


While, as noted, various types of films may be used for the stent covering, the described ePTFE films is preferred because of its multiaxial (within the plane of the film) strength orientation. It is strong, thin, and has excellent biocompatibility. When suitable heat is applied following slitting, the film will retract (shrink back) with good uniformity to create the openings through the polymeric stent covering and to create the flexible polymeric interconnecting webs between adjacent stent elements.


The flexible interconnecting webs 32 that result from this process typically are of wider width at their end points where they connect with the wire apices and are of comparatively narrower width in the middle of their lengths between the apices that they interconnect. Additionally, there may be a very thin, vestigial edge (36, FIG. 2B) of film that extends outwardly away from the wire 18 in the straight portions 24 that connect the apices in the same helical winding (i.e., apices 22a and 22b). FIG. 5A shows a transverse cross section of the wire with this edge (taken at section 5 indicated in the plan view of FIG. 2B) that shows the general appearance of the edge for a single layer of graft material applied to either the outer or inner surface of the stent. FIGS. 5B and 5C show the transverse cross section as it would appear for a covering applied to both the inner and outer surfaces of the stent element.


A preferred method of making a flexible stent is as follows. A stainless steel mandrel of diameter equal to about the inside diameter of the intended stent is obtained. The surface of the mandrel is provided with a helical wrapping of a 1″ wide tape of Kapton® Polyimide Film (DuPont, 0.002 inch thickness). A stent of the desired length and diameter made of helically wound serpentine nitinol wire is provided (wire diameter as desired). This is then wound around the Kapton covered surface of the mandrel. The end of the stent wires are secured to an adjacent winding of the stent wire using an FEP thread tied with a securing knot. The apices of the serpentine wire are aligned so that apices pointing in a common direction are aligned with and parallel to the longitudinal axis of the mandrel. The stent is then helically wrapped with a covering of a single layer of FEP tape that has been cut from FEP film (0.00015 inch thickness and about 0.75 inch width), stretched tight over the outer surface of the stent with minimal overlap of adjacent edges of the FEP tape. This FEP tape is then cigarette wrapped (wrapped in a direction perpendicular to the longitudinal axis of the mandrel) with an ePTFE film of the type described previously. This wrapping may be started by aligning a transverse edge of the film with the longitudinal axis of the mandrel and attaching it to the underlying FEP film by carefully melt-bonding the ePTFE film edge to the FEP using a heat source such as a clean soldering iron or appropriate equivalent. Six layers of the ePTFE film are wrapped around the outer surface of the stent and the film edge is trimmed along the length of the stent (i.e., parallel to the longitudinal axis of the mandrel). The film edge is secured with the previously-used heat source.


Longitudinal slits 41 are created between adjacent wire apices that are pointed in the same direction as shown by FIG. 4. These slits may be created by any suitable means, including the use of a scalpel blade, water jet, laser, etc. One such suitable laser is a Coherent Inc., Model: GEM-100A, CO2, CW (continuous wave only), Santa Clara, CA The last row of apices at each end of the stent may be omitted from slitting if it is desired to leave these end rows covered in their entirety (i.e., in stent-graft fashion). The entire length of the wrapped stent is then provided with an additional, temporary helical wrap of the Kapton tape; the ends of this tape may be secured to the surface of the mandrel beyond each end of the stent with a mechanical clip or other temporary fastener. This layer of Kapton is then tightly wrapped with a temporary helical wrap of ePTFE tape (made from an ePTFE film having a fibrillar microstructure with fibrils oriented predominately parallel to the length of the tape and wrapped with a small pitch angle so that the orientation is primarily circumferential with respect to the mandrel). This ePTFE tape will provide circumferential compression to the underlying materials when suitably heated.


The above construction is them placed into a suitable convection oven set at 380° C. for 11 minutes, after which it is removed from the oven and allowed to cool to approximately ambient temperature. The outer layers of ePTFE film and Kapton tape are then removed. The resulting coated stent and underlying layer of Kapton tape are then carefully removed from the mandrel. The remaining layer of Kapton tape may then be removed from the stent using a suitable tool such as small forceps or tweezers. Remaining film edges protruding beyond the ends of the stent may then be carefully trimmed in a transverse direction close to the end apices of the stent wire with a scalpel blade.



FIG. 6A shows a perspective view of a balloon expandable stent 60, as it appears following diametrical expansion with a balloon that is preferred for use as described herein. The stent 60 shown comprises rings 62 wherein the balloon-expanded stent elements form multiple diamond-shaped openings 63d; stent 60 is typically comprised of one or more of these rings 62. The individual rings 62 may be constructed by any suitable means known in art but are preferably fabricated from a laser cut tube. For clarity, only the side of the tubular stent 60 closest to the viewer is shown. Stent 60 is provided with a polymeric covering 66, preferably of a flexible film. It is apparent how covering 66 interconnects the multiple rings 62 to create stent 60, via webs 32 that span the distance between apices 22a and 22b of adjacent rings 62.


While various polymeric films may be suitable for use as the stent covering (or coating) material for this device, combinations of FEP (fluorinated ethylene propylene) films used in combination with ePTFE films are preferred. The preferred ePTFE film for this device is a uni-axial film having higher strength in one direction, with the direction primarily aligned with the longitudinal axis 61 of the stent prior to balloon expansion. This type of film is similar to that described in U.S. Pat. No. 5,476,589. A further preference would be to modify the film with an application of a discontinuous coating of FEP similar to that taught in U.S. Pat. No. 6,159,565.


The arrangement of stent rings 62 are shown in FIG. 6B without polymeric covering 66 as the rings 62 would appear prior to balloon expansion. Unexpanded stent rings 62 are cut to have openings 63 which become diamond shaped openings 63d when expanded (as shown in FIG. 6A). Stent rings 62 are placed in proximity to one another with apices 22a and 22b in a typical apex to apex alignment. It is apparent that the distance between adjacent rings 62 may be as desired.



FIG. 6C illustrates the stent rings 62 as shown previously in FIG. 6B with the addition of interconnecting polymeric covering 66. Webs 32, each a portion of polymeric covering 66, are shown to interconnect adjacent rings 62. FIG. 6D is an enlarged detail perspective view of the upper left end of stent 60 described in FIG. 6C.


Also shown in FIGS. 6C and 6D are punctures or slits 68 arranged in polymeric covering 66 along the longitudinal axis of stent 60. FIGS. 6B-6D show the multiplicity of openings 63 and 64 formed between adjacent stent elements of stent rings 62. Slits 68 through polymeric covering 66 are formed of size and shape to generally correspond with the multiplicity of openings 63 and 64 in each stent ring 62. These slits 68 may be formed by various means as previously described. Slits 68 are formed through the polymeric covering 66 that covers openings 63 that extend between opposing apices 22a and 22b (openings that are enclosed between the ends of each stent ring 62). Alternate openings 64 that extend from the middle of the length of each stent ring 62 and fully to the end of each stent ring 62 (i.e. between radially adjacent apices 22a and 22a, and likewise between radially adjacent apices 22b and 22b) are also provided with slits through the covering polymeric material 66. These slits 68 extend longitudinally between adjacent rings 62 and into the corresponding opening in the adjacent ring 62. These slits 68 collectively create individual interconnecting webs 32. Slits 68 may be of width as desired; the width of a scalpel blade may be deemed sufficient even though the figures show that width of slit 68 corresponding to the width of the underlying stent openings 63 and 64.


The apices 22a and 22b of each ring 62 may be made to point toward one another as shown in FIG. 6A or may be arranged to be offset as shown in FIG. 7 (i.e. aligned peak-to-valley as shown in FIG. 7 as opposed to being aligned in peak-to-peak fashion as shown in FIGS. 1A through 2D, FIG. 4 and FIG. 6A). The apices typically “point” in directions that are substantially parallel to the longitudinal axis 61 of the tubular form of the stent 60.



FIG. 8 is a schematic side view of stent 60 as it would appear mounted on a balloon (not shown) for subsequent deployment and expansion. Stent 60 is preferably axially compressed during mounting so that Interconnecting webs 32 are bowed or wrinkled so that stent 60 is foreshortened. The advantage of mounting stent 60 in this fashion is that, during balloon expansion, stent rings 62 will foreshorten as they are deformed (with openings 63 becoming diamond shaped openings 63d). For example, this allows for less than 10% shortening with a greater than 6 times diametrical expansion. Bowed webs 32 may be tucked under adjacent stent ring 62 if it is preferred that they do not protrude outwardly. A preferred balloon is a balloon that expands diametrically from the middle of its length toward its opposing ends. Alternatively, stent rings 62 at the ends of stent 60 may be made of a thicker material than ring 62 positioned closer to the middle of the length of stent 60. These alternatives result in the application of tension during expansion to bowed webs 32 thereby pulling the slack out of them, increasing their length and compensating for foreshortening of rings 62 to maintain the length of stent 60.


A preferred method of making a stent such as a stent shown in FIGS. 6A through 7 is as follows. Standard diamond pattern geometry stents were laser machined and electro-polished at Laserage Technology Inc, Waukegan, IL from a 316 LVM stainless steel tube measuring 4.19 mm diameter×0.38 mm wall thickness, available from Norman Noble, Cleveland OH. The stents were exposed to a surface roughening step to improve adherence without degrading fatigue durability performance. Plasma treatment of the stents was performed prior to FEP powder coating for purposes of cleaning and reducing contact angle of the metal surface. Plasma treatment was performed as commonly known in the arts.


FEP powder (Daikin America, Orangeburg N.Y.) was applied to the stent component by first stirring the powder into an airborne “cloud” in a standard kitchen-type blender and suspending the frame in the cloud until a uniform layer of powder was attached to the stent frame. The stent component was then subjected to a thermal treatment of 320° C. for approximately three minutes. This caused the powder to melt and adhere as a coating over the stent component. Each ring was coated a second time while suspending it from the opposite end and placed in 320° C. oven for 3 minutes then removed and allowed to cool to room temperature.


Seventeen layers of a thin ePTFE film provided with a discontinuous coating of FEP as previously described was then wrapped around a stainless steel mandrel measuring approx 3.43 mm. The film is applied with its high strength orientation parallel to the longitudinal axis of the stent and with the FEP side facing out. Individual stent rings were placed over the film tube and aligned. In this case, the stent rings were aligned apex to apex and separated evenly with a gap of about 2.5 mm between each ring to achieve an overall device length of about 40 mm. An additional 17 layers of the same film was applied as previously described except with the FEP side oriented down, toward the outer diameter of the stent.


The entire assembly was wound with several layers of an ePTFE thread (Part #SO24T4, WL Gore, Elkton, MD) to impart compressive forces to the underlying construct. The assembly was placed in 320° c. oven (Grieves, Model MT1000, The Grieve Corporation, Round Lake, IL) for approximately 40 minutes. The stent assembly was removed and allowed to cool to room temperature. The over-wrap was then removed and the slits were created and excess material was removed.


While particular embodiments of the present invention have been illustrated and described herein, the present invention should not be limited to such illustrations and descriptions. It should be apparent that changes and modifications may be incorporated and embodied as part of the present invention within the scope of the following claims.

Claims
  • 1. A stent comprising multiple rows of stent elements, each row of said stent elements incorporating apices wherein an apex of one row is interconnected to a pair of apices of an adjacent row by a connector consisting of a pair of film webs.
  • 2. A stent according to claim 1, wherein said rows of stent elements are in the form of helically wound serpentine wire.
  • 3. A stent according to claim 1, wherein said film comprises ePTFE.
  • 4. A stent according to claim 3, wherein said film further comprises fluorinated ethylene propylene.
  • 5. A stent according to claim 1, wherein said stent elements comprise multiple rings, wherein the rings have diamond shaped openings through each ring following diametrical expansion.
  • 6. A stent according to claim 1, wherein said film webs are melt-bonded to said stent elements.
  • 7. A stent according to claim 1, wherein said stent has a length and said film webs are continuous along said length.
  • 8. A stent comprising multiple stent elements incorporating a plurality of apices wherein three adjacent apices are interconnected by a connector consisting of a pair of film webs.
  • 9. A stent according to claim 8, wherein said stent has a length and said film webs are continuous along said length.
  • 10. A stent according to claim 8, wherein said webs comprise ePTFE.
  • 11. A stent according to claim 10, wherein said webs further comprise fluorinated ethylene propylene.
  • 12. A stent according to claim 8, wherein said stent elements comprise helically wound serpentine wire.
  • 13. A stent according to claim 8, wherein said stent elements comprise multiple individual rings.
  • 14. A stent comprising multiple rows of stent elements, each row of said stent elements being spaced apart from one another in a lengthwise direction of said stent, each row of said stent elements incorporating apices wherein an apex of one row is connected to a pair of apices of an adjacent row by a pair of film webs, wherein the film webs serve to limit axial elongation of the stent.
  • 15. A stent according to claim 14, wherein said rows of stent elements are in the form of helically wound serpentine wire.
  • 16. A stent according to claim 14, wherein said film comprises ePTFE.
  • 17. A stent according to claim 16, wherein said film further comprises fluorinated ethylene propylene.
  • 18. A stent according to claim 14, wherein said stent elements comprise multiple rings having diamond shaped openings through each ring following diametrical expansion.
  • 19. A stent according to claim 14, wherein said film webs are melt-bonded to said stent elements.
  • 20. A stent according to claim 14, wherein said stent has a length and said film webs are continuous along said length.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 15/915,453, filed Mar. 8, 2018, which is a continuation of U.S. application Ser. No. 13/349,346, filed Jan. 12, 2012, now U.S. Pat. No. 9,943,428, issued Apr. 17, 2018, which is a continuation of U.S. application Ser. No. 12/350,921, filed Jan. 8, 2009, now U.S. Pat. No. 8,926,688, issued Jan. 6, 2015, which claims the benefit of U.S. Provisional Patent Application No. 61/020,544, filed on Jan. 11, 2008, all of which are incorporated herein by reference in their entireties for all purposes.

US Referenced Citations (323)
Number Name Date Kind
4503569 Dotter Mar 1985 A
4655771 Wallsten Apr 1987 A
4739762 Palmaz Apr 1988 A
4776337 Palmaz Oct 1988 A
4884573 Wijay et al. Dec 1989 A
5019090 Pinchuk May 1991 A
5037427 Harada et al. Aug 1991 A
5061275 Wallsten et al. Oct 1991 A
5102417 Palmaz Apr 1992 A
5104404 Wolff Apr 1992 A
5122154 Rhodes Jun 1992 A
5123917 Lee Jun 1992 A
5201757 Heyn et al. Apr 1993 A
5236447 Kubo et al. Aug 1993 A
5282824 Gianturco Feb 1994 A
5300500 Lee et al. Apr 1994 A
5314472 Fontaine May 1994 A
5330500 Song Jul 1994 A
5360443 Barone et al. Nov 1994 A
5405377 Cragg Apr 1995 A
5409495 Osborn Apr 1995 A
5443495 Buscemi et al. Aug 1995 A
5443496 Schwartz et al. Aug 1995 A
5443499 Schmitt Aug 1995 A
5449373 Pinchasik et al. Sep 1995 A
5507767 Maeda et al. Apr 1996 A
5507771 Gianturco Apr 1996 A
5549663 Cottone, Jr. Aug 1996 A
5575816 Rudnick et al. Nov 1996 A
5591195 Taheri et al. Jan 1997 A
5613979 Trotta et al. Mar 1997 A
5662703 Yurek et al. Sep 1997 A
5665115 Cragg Sep 1997 A
5674241 Bley et al. Oct 1997 A
5683448 Cragg Nov 1997 A
5693086 Goicoechea et al. Dec 1997 A
5708044 Branca Jan 1998 A
5725570 Heath Mar 1998 A
5728150 McDonald et al. Mar 1998 A
5735892 Myers et al. Apr 1998 A
5749852 Schwab et al. May 1998 A
5755774 Pinchuk May 1998 A
5756553 Iguchi et al. May 1998 A
5769884 Solovay Jun 1998 A
5769887 Brown et al. Jun 1998 A
5800456 Maeda et al. Sep 1998 A
5800515 Nadal et al. Sep 1998 A
5800521 Orth Sep 1998 A
5814063 Freitag Sep 1998 A
5824043 Cottone, Jr. Oct 1998 A
5824059 Wijay Oct 1998 A
5843092 Heller et al. Dec 1998 A
5843161 Solovay Dec 1998 A
5873906 Lau et al. Feb 1999 A
5876432 Lau et al. Mar 1999 A
5879369 Ishida Mar 1999 A
5891193 Robinson et al. Apr 1999 A
5899934 Amundson et al. May 1999 A
5906639 Rudnick et al. May 1999 A
5919225 Lau et al. Jul 1999 A
5922020 Klein et al. Jul 1999 A
5968091 Pinchuk et al. Oct 1999 A
5984957 Laptewicz et al. Nov 1999 A
6001125 Golds et al. Dec 1999 A
6004348 Banas et al. Dec 1999 A
6007545 Venturelli Dec 1999 A
6013854 Moriuchi Jan 2000 A
6015432 Rakos et al. Jan 2000 A
6016846 Knittel et al. Jan 2000 A
6022359 Frantzen Feb 2000 A
6022374 Imran Feb 2000 A
6048360 Khosravi et al. Apr 2000 A
6071307 Rhee et al. Jun 2000 A
6077296 Shokoohi et al. Jun 2000 A
6107004 Donadio, III Aug 2000 A
6123712 Di et al. Sep 2000 A
6139573 Sogard et al. Oct 2000 A
6139575 Shu et al. Oct 2000 A
6143022 Shull et al. Nov 2000 A
6146417 Ischinger Nov 2000 A
6159219 Ren Dec 2000 A
6159239 Greenhalgh Dec 2000 A
6165210 Lau et al. Dec 2000 A
6171334 Cox Jan 2001 B1
6174328 Cragg Jan 2001 B1
6217609 Haverkost Apr 2001 B1
6231597 Deem et al. May 2001 B1
6264687 Tomonto Jul 2001 B1
6283990 Kanesaka Sep 2001 B1
6283992 Hankh et al. Sep 2001 B1
6287333 Appling et al. Sep 2001 B1
6290722 Wang Sep 2001 B1
6312458 Golds Nov 2001 B1
6315791 Gingras et al. Nov 2001 B1
6315792 Armstrong et al. Nov 2001 B1
6331188 Lau et al. Dec 2001 B1
6331190 Shokoohi et al. Dec 2001 B1
6334868 Ham Jan 2002 B1
6336937 Vonesh et al. Jan 2002 B1
6340366 Wijay Jan 2002 B2
6344054 Parodi Feb 2002 B1
6350277 Kocur Feb 2002 B1
6355055 Waksman et al. Mar 2002 B1
6357104 Myers Mar 2002 B1
6361637 Martin et al. Mar 2002 B2
6364903 Tseng et al. Apr 2002 B2
6387122 Cragg May 2002 B1
6398803 Layne et al. Jun 2002 B1
6409754 Smith et al. Jun 2002 B1
6419685 Di et al. Jul 2002 B2
6432133 Lau et al. Aug 2002 B1
6436132 Patel et al. Aug 2002 B1
6451050 Rudakov et al. Sep 2002 B1
6461380 Cox Oct 2002 B1
6464718 Miller et al. Oct 2002 B1
6488701 Nolting et al. Dec 2002 B1
6488705 Schmitt et al. Dec 2002 B2
6497722 Von et al. Dec 2002 B1
6500203 Thompson et al. Dec 2002 B1
6503556 Harish et al. Jan 2003 B2
6506202 Dutta et al. Jan 2003 B1
6511496 Huter et al. Jan 2003 B1
6520986 Martin et al. Feb 2003 B2
6527739 Bigus et al. Mar 2003 B1
6537311 Cox et al. Mar 2003 B1
6540773 Dong Apr 2003 B2
6540776 Sanders et al. Apr 2003 B2
6541589 Baillie Apr 2003 B1
6551350 Thornton et al. Apr 2003 B1
6551352 Clerc et al. Apr 2003 B2
6554848 Boylan et al. Apr 2003 B2
6558414 Layne May 2003 B2
6558415 Thompson May 2003 B2
6565599 Hong et al. May 2003 B1
6579305 Lashinski Jun 2003 B1
6585755 Jackson et al. Jul 2003 B2
6589275 Ivancev et al. Jul 2003 B1
6589276 Pinchasik et al. Jul 2003 B2
6602284 Cox et al. Aug 2003 B2
6605056 Eidenschink et al. Aug 2003 B2
6607551 Sullivan et al. Aug 2003 B1
6616689 Ainsworth et al. Sep 2003 B1
6620128 Simhambhatla Sep 2003 B1
6620193 Lau et al. Sep 2003 B1
6626939 Burnside et al. Sep 2003 B1
6629992 Bigus et al. Oct 2003 B2
6645239 Park et al. Nov 2003 B1
6652574 Jayaraman Nov 2003 B1
6652579 Cox et al. Nov 2003 B1
6669719 Wallace et al. Dec 2003 B2
6673103 Golds et al. Jan 2004 B1
6689162 Thompson Feb 2004 B1
6709454 Cox et al. Mar 2004 B1
6712357 Tranquilla Mar 2004 B1
6713357 Wang et al. Mar 2004 B1
6730117 Tseng et al. May 2004 B1
6740114 Burgermeister May 2004 B2
6749584 Briggs et al. Jun 2004 B2
6770087 Layne et al. Aug 2004 B2
6770089 Hong et al. Aug 2004 B1
6776771 Van et al. Aug 2004 B2
6805705 Hong et al. Oct 2004 B2
6849086 Cragg Feb 2005 B2
6866805 Hong et al. Mar 2005 B2
6872433 Seward et al. Mar 2005 B2
6881216 Di et al. Apr 2005 B2
6881221 Golds Apr 2005 B2
6887266 Williams et al. May 2005 B2
6893457 Dong May 2005 B2
6923827 Campbell et al. Aug 2005 B2
6945991 Brodeur et al. Sep 2005 B1
6960186 Fukaya et al. Nov 2005 B1
7105018 Yip et al. Sep 2006 B1
7105021 Edens et al. Sep 2006 B2
7108716 Burnside et al. Sep 2006 B2
7112293 Dubson et al. Sep 2006 B2
7115220 Dubson et al. Oct 2006 B2
7118592 Dang et al. Oct 2006 B1
7141062 Pinchasik et al. Nov 2006 B1
7144422 Rao Dec 2006 B1
7163533 Hobbs et al. Jan 2007 B2
7163553 Limon Jan 2007 B2
7186263 Golds et al. Mar 2007 B2
7258697 Cox et al. Aug 2007 B1
7273495 Limon Sep 2007 B2
7288111 Holloway et al. Oct 2007 B1
7314480 Eidenschink et al. Jan 2008 B2
7323008 Kantor et al. Jan 2008 B2
7329276 Smith et al. Feb 2008 B2
7384411 Condado Jun 2008 B1
7455687 Saunders et al. Nov 2008 B2
7510571 Spiridigliozzi et al. Mar 2009 B2
7540879 Lualdi Jun 2009 B2
7578831 Von et al. Aug 2009 B2
7686841 Eidenschink et al. Mar 2010 B2
7691461 Prabhu Apr 2010 B1
7704274 Boyle et al. Apr 2010 B2
7727271 Kujawski et al. Jun 2010 B2
7967836 Warnack et al. Jun 2011 B2
8066667 Hayman et al. Nov 2011 B2
8221484 Wesselmann Jul 2012 B2
8257432 Kaplan et al. Sep 2012 B2
8444686 Holman et al. May 2013 B2
8585640 Alpini et al. Nov 2013 B2
8597566 Eskaros et al. Dec 2013 B2
8672990 Holman et al. Mar 2014 B2
8858863 Venturelli Oct 2014 B2
8926688 Burkart et al. Jan 2015 B2
8979886 Campbell et al. Mar 2015 B2
9149612 Chuter Oct 2015 B2
9370643 Hedberg et al. Jun 2016 B2
9370647 Campbell et al. Jun 2016 B2
9622888 Armstrong et al. Apr 2017 B2
9669194 Campbell et al. Jun 2017 B2
9682219 Venturelli Jun 2017 B2
9770352 Kanjickal et al. Sep 2017 B2
9901715 Cully et al. Feb 2018 B2
9943428 Burkart et al. Apr 2018 B2
10299948 Bohn et al. May 2019 B2
10456281 Armstrong et al. Oct 2019 B2
10463519 Aggerholm et al. Nov 2019 B2
10470905 Yang et al. Nov 2019 B2
10543116 Bohn et al. Jan 2020 B2
10568752 Kovach et al. Feb 2020 B2
20010020181 Layne Sep 2001 A1
20010025130 Tomonto Sep 2001 A1
20010032009 Layne Oct 2001 A1
20020007102 Salmon et al. Jan 2002 A1
20020013617 Matsutani et al. Jan 2002 A1
20020049408 Van et al. Apr 2002 A1
20020077690 Wang Jun 2002 A1
20020099431 Armstrong Jul 2002 A1
20020111668 Smith Aug 2002 A1
20020151964 Smith et al. Oct 2002 A1
20020165601 Clerc Nov 2002 A1
20030060756 Hayman et al. Mar 2003 A1
20030208260 Lau et al. Nov 2003 A1
20030236563 Fifer Dec 2003 A1
20040019373 Casey et al. Jan 2004 A1
20040024442 Sowinski et al. Feb 2004 A1
20040024448 Chang et al. Feb 2004 A1
20040030377 Dubson et al. Feb 2004 A1
20040033364 Spiridigliozzi et al. Feb 2004 A1
20040096532 Dubson et al. May 2004 A1
20040096533 Dubson et al. May 2004 A1
20040106980 Solovay et al. Jun 2004 A1
20040143272 Cully et al. Jul 2004 A1
20040167635 Yachia et al. Aug 2004 A1
20040172127 Kantor Sep 2004 A1
20040236402 Layne et al. Nov 2004 A1
20050004647 Bassoe Jan 2005 A1
20050010281 Yodfat et al. Jan 2005 A1
20050125071 Nahleili Jun 2005 A1
20050137675 Dubson et al. Jun 2005 A1
20050154449 Elmaleh Jul 2005 A1
20050182474 Jones et al. Aug 2005 A1
20050186243 Hunter et al. Aug 2005 A1
20050209672 George et al. Sep 2005 A1
20050228480 Douglas et al. Oct 2005 A1
20060009835 Osborne et al. Jan 2006 A1
20060036308 Goshgarian Feb 2006 A1
20060036311 Nakayama et al. Feb 2006 A1
20060085065 Krause et al. Apr 2006 A1
20060122691 Richter Jun 2006 A1
20060184237 Weber et al. Aug 2006 A1
20060190072 Das Aug 2006 A1
20060259133 Sowinski et al. Nov 2006 A1
20060266474 Burnside et al. Nov 2006 A1
20060271091 Campbell et al. Nov 2006 A1
20060271157 Edens et al. Nov 2006 A1
20060271165 Yip et al. Nov 2006 A1
20060287709 Rao Dec 2006 A1
20060293743 Andersen et al. Dec 2006 A1
20070055365 Greenberg et al. Mar 2007 A1
20070073383 Yip et al. Mar 2007 A1
20070129791 Balaji Jun 2007 A1
20070208412 Elmaleh Sep 2007 A1
20070239264 Fliedner Oct 2007 A1
20070250146 Cully et al. Oct 2007 A1
20080161901 Heuser et al. Jul 2008 A1
20080319388 Slattery et al. Dec 2008 A1
20090054967 Das Feb 2009 A1
20090069878 Weber et al. Mar 2009 A1
20090138070 Holzer et al. May 2009 A1
20090182413 Burkart et al. Jul 2009 A1
20090234429 Lau Sep 2009 A1
20090283206 Eskaros et al. Nov 2009 A1
20100069839 Holman et al. Mar 2010 A1
20100222870 Kaplan et al. Sep 2010 A1
20100228333 Drasler et al. Sep 2010 A1
20110087191 Scheuermann Apr 2011 A1
20120071912 Campbell et al. Mar 2012 A1
20120109283 Burkart et al. May 2012 A1
20120253380 Venturelli Oct 2012 A1
20120330232 Hedberg et al. Dec 2012 A1
20130018406 Campbell et al. Jan 2013 A1
20130184807 Kovach et al. Jul 2013 A1
20130253466 Campbell et al. Sep 2013 A1
20140066896 Tilson et al. Mar 2014 A1
20140066897 Campbell et al. Mar 2014 A1
20140066898 Cully et al. Mar 2014 A1
20140135891 Poehlmann et al. May 2014 A1
20140142684 Zukowski May 2014 A1
20140172066 Goepfrich et al. Jun 2014 A1
20140276406 Campbell et al. Sep 2014 A1
20140277331 Ngo et al. Sep 2014 A1
20140277346 Kanjickal et al. Sep 2014 A1
20140277374 Kovach Sep 2014 A1
20140378896 Venturelli Dec 2014 A1
20150133988 Chuter May 2015 A1
20160143759 Bohn et al. May 2016 A1
20160243340 Campbell et al. Aug 2016 A1
20170172776 Kanjickal et al. Jun 2017 A1
20170340464 Kovach et al. Nov 2017 A1
20170340465 Kanjickal et al. Nov 2017 A1
20180049898 Armstrong et al. Feb 2018 A1
20180193177 Burkart et al. Jul 2018 A1
20180296377 Bohn et al. Oct 2018 A1
20190298556 Bohn et al. Oct 2019 A1
20190388252 Armstrong et al. Dec 2019 A1
20200253763 Kovach et al. Aug 2020 A1
20210236314 Bohn et al. Aug 2021 A1
20220168124 Bohn et al. Jun 2022 A1
Foreign Referenced Citations (57)
Number Date Country
101636130 Jan 2010 CN
101822868 Sep 2010 CN
102940543 Feb 2013 CN
103561686 Feb 2014 CN
103702709 Apr 2014 CN
103930157 Jul 2014 CN
103930158 Jul 2014 CN
0745395 Dec 1996 EP
0951877 Oct 1999 EP
1110561 Jun 2001 EP
1550477 Jul 2005 EP
1927327 Jun 2008 EP
09-099087 Apr 1997 JP
11-299901 Nov 1999 JP
2002-501404 Jan 2002 JP
2005-535414 Nov 2005 JP
2010-500107 Jan 2010 JP
2014-520632 Aug 2014 JP
2014-530045 Nov 2014 JP
2015-534883 Dec 2015 JP
9517223 Jun 1995 WO
9526695 Oct 1995 WO
9621404 Jul 1996 WO
9831305 Jul 1998 WO
9917680 Apr 1999 WO
9934855 Jul 1999 WO
0042949 Jul 2000 WO
0043051 Jul 2000 WO
0045741 Aug 2000 WO
0049971 Aug 2000 WO
0121101 Mar 2001 WO
0222024 Mar 2002 WO
0313337 Feb 2003 WO
0307795 Apr 2003 WO
0357075 Jul 2003 WO
0357077 Jul 2003 WO
2004016199 Feb 2004 WO
2004093941 Nov 2004 WO
2005096997 Oct 2005 WO
2006029617 Mar 2006 WO
2006081568 Aug 2006 WO
2006124824 Nov 2006 WO
2008019022 Feb 2008 WO
2009009635 Jan 2009 WO
2009066330 May 2009 WO
2010037141 Apr 2010 WO
2013009740 Jan 2013 WO
2013040522 Mar 2013 WO
2013096854 Aug 2013 WO
2013162685 Oct 2013 WO
2014078558 May 2014 WO
2014152684 Sep 2014 WO
2014158516 Oct 2014 WO
2015073114 May 2015 WO
2016086202 Jun 2016 WO
2017204838 Nov 2017 WO
2018039444 Mar 2018 WO
Non-Patent Literature Citations (5)
Entry
International Search Report and Written Opinion from PCT/US2009/000144, dated May 6, 2009, 14 pages.
Nakayama Y, Nishi S, Ueda H, et al. Fabrication of micropored elastomeric film covered stents and acute-phase performances. Development of Covered Stents 2002; 52-61.
Nakayama, Y. et al., “Fabrication of micorpored elastomeric film-covered stents and acute-phase performances,” Development of Covered Stents, 2002; 52-61.
Nishi, S. et al., “Newly Developed Stent Graft with Micropored and Heparin Impregnated SPU Film, Long-Term Follow-up Study in Vivo”, Interventional Neuroradiology, 7 (Suppl 1): 161-166, 2001.
Wilson, Eric et al., “Deployment and Healing of an ePTFE Encapsulated Stent Endograft in the Canine Aorta,” Annals of Vascular Surgery, (1997), vol. 11, No. 4, pp. 354-358.
Related Publications (1)
Number Date Country
20210361451 A1 Nov 2021 US
Provisional Applications (1)
Number Date Country
61020544 Jan 2008 US
Continuations (3)
Number Date Country
Parent 15915453 Mar 2018 US
Child 17397362 US
Parent 13349346 Jan 2012 US
Child 15915453 US
Parent 12350921 Jan 2009 US
Child 13349346 US